US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Weight Loss Drugs

1,203.44

+13.331.12%

Number of Gainers:7

Number of Losers:- -

Number of Flat:- -

PE:- -

High:1,212.36

Open:1,190.62

Low:1,186.95

Close:1,190.11

Volume:35.93M

Turnover:2.45B

Market Cap:1.28T

Float Cap:1.20T

Loading ...

Data on Eli Lilly's Weight Loss Pill Hasn't Thrilled Investors. New Updates Are Complicating the Picture. -- Barrons.com

Eli Lilly receives up to $8B contract from Veterans Affairs

GLP-1 drugs could save millions of lives - and spark a pension crisis

Lilly's Oral Glp-1, Orforglipron, Superior to Oral Semaglutide in Head-to-Head Trial

THOMSON REUTERS

Eli Lilly: Orforglipron Met Primary, All Key Secondary Endpoints Across Each Dose Comparison VS Oral Semaglutide

THOMSON REUTERS

Citi Remains a Buy on Eli Lilly & Co (LLY)

Eli Lilly Cut to Hold From Buy by Berenberg

Eli Lilly Bets on Consumer-Oriented Strategy, Expects Weight Loss Drug Breakthrough in US Market

2 High-Yield Dividend Stocks You'll Wish You Had Bought 10 Years From Now

Novo-Nordisk A/S (NVO.US) Weight-Loss Drug Patents Set to Expire in Multiple Markets Next Year as Indian API Manufacturers Target $94 Billion Market

Eli Lilly's International President Says Co Looking Into New FDA Fast-Track Review Process but Cannot Assume New Obesity Pill Could Be Approved This Way

THOMSON REUTERS

Eli Lilly’s International President Says Co Has Partnered With Telehealth Platforms Run by Alibaba & Jd to Boost Obesity Drug Awareness, Sales in China

THOMSON REUTERS

Eli Lilly's International President Says Co Replicating U.S. Consumer-Focused Obesity Strategy in UK, China, UAE, Australia, Elsewhere

THOMSON REUTERS

Novo Nordisk Has Opportunities to Seize After Market Reset -- Market Talk

Eli Lilly : Berenberg Cuts to Hold From Buy; Cuts Target Price to $830 From $970

THOMSON REUTERS

GSK Says It Will Spend $30B on U.S. Manufacturing and R&D -- Barrons.com

Moderna Inc. Stock Rises 4.0%, Outperforms Peers

Stock Of The Day: Is The Novo Nordisk Death Spiral Finally Over?

Benzinga_recent_news

FDA sends Novo Nordisk warning letter over weight loss video

Eli Lilly Plans $5 Billion Investment for New Manufacturing Facility in Virginia

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4599/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"Weight Loss Drugs","latestPrice":1203.437,"timestamp":1758125203982,"preClose":1190.1115,"halted":0,"volume":35928630,"delay":0,"changeRate":0.011197,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":13.325562,"latestTime":"09-17 12:06:44 EDT","open":1190.6204,"high":1212.3625,"low":1186.9506,"amount":2450791094.451567,"amplitude":0.021353,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1758139200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":8.495193,"peRate":25.087415,"turnoverRate":0.003396,"increases":7,"decrements":0,"flats":0,"marketCap":1279292573472,"floatMarketCap":1203632694464},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1212.3625,"amplitude":0.021353,"preClose":1190.1115,"low":1186.9506,"pbRate":"8.495193","latestPrice":1203.437,"volume":35928627,"delay":0,"open":1190.6204,"prevYearClose":1305.0607,"prevWeekClose":1175.5227,"prevMonthClose":1170.4948,"prevQuarterClose":1245.5326,"fiveDayClose":1178.581,"twentyDayClose":1143.9899,"sixtyDayClose":1235.2372,"secType":"PLATE","market":"US","turnoverRate":0.003396,"peRate":25.087415,"marketCap":1279292573472,"floatMarketCap":1203632694464,"timestamp":1758125203442,"nameCN":"Weight Loss Drugs"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":7,"down":0,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2568217492","title":"Data on Eli Lilly's Weight Loss Pill Hasn't Thrilled Investors. New Updates Are Complicating the Picture. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2568217492","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568217492?lang=en_us&edition=fundamental","pubTime":"2025-09-17 22:35","pubTimestamp":1758119700,"startTime":"0","endTime":"0","summary":"The drugmaker Eli Lilly's reign as the undisputed king of the weight loss trade came under threat in early August, after disappointing preliminary data on its closely watched experimental weight loss pill set off a 14% single-day selloff.This week, an avalanche of new data on the pill isn't dramatically improving the picture.Investors had hoped that Lilly's experimental pill, orforglipron, would work better as an obesity treatment than Novo Nordisk's injection Wegovy, and that patients looking for a more convenient option might choose it instead.That didn't pan out in early August, when Lilly said patients on their pill lost 12.4% of their weight on average over 72 weeks, short of the 15% weight loss Wegovy delivered in earlier trials. An oral version of Wegovy, now under Food and Drug Administration review, has also demonstrated 15% weight loss.Still, Meacham said that the tolerability wouldn't be an issue for the drug's uptake. \"We think the tolerability profile is mostly benign and ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2552382132.HKD","LU1720051108.HKD","SGXZ31699556.SGD","LU2211815571.USD","LU1868837300.USD","SGXZ81514606.USD","LU0320765059.SGD","SG9999001176.USD","LU2236285917.USD","LU1291159041.SGD","LU0823434740.USD","LU2237443895.HKD","LU0320765992.SGD","LU2237443465.HKD","LU0943347566.SGD","LU0109394709.USD","LU0417517546.SGD","BK4211","LU1064131342.USD","IE0004445239.USD","LU1868836757.USD","BK4588","LU2491049909.HKD","LU0385154629.USD","LU0006306889.USD","BK4532","IE00B1BXHZ80.USD","LU1983299246.USD","SG9999018857.SGD","LLY","IE00BFTCPJ56.SGD","LU0061475181.USD","LU0786609619.USD","LU0820561818.USD","LU2456880835.USD","LU0689472784.USD","LU2602419157.SGD","BK4516","LU0238689110.USD","LU2063271972.USD","LU2237443382.USD","ISBC","BK4599","SG9999015978.USD","LU1035775433.USD","LU1267930730.SGD","LU0094547139.USD","LU0466842654.USD","IE00BK4W5L77.USD"],"gpt_icon":1},{"id":"2568497886","title":"Eli Lilly receives up to $8B contract from Veterans Affairs","url":"https://stock-news.laohu8.com/highlight/detail?id=2568497886","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568497886?lang=en_us&edition=fundamental","pubTime":"2025-09-17 22:25","pubTimestamp":1758119125,"startTime":"0","endTime":"0","summary":"The Department of Veterans Affairs posted a contract for Eli Lilly (LLY) worth up to $8B. Published first on TheFly – the ultimate source for real-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eli-lilly-receives-up-to-8b-contract-from-veterans-affairs-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eli-lilly-receives-up-to-8b-contract-from-veterans-affairs-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443382.USD","LU0417517546.SGD","SG9999015945.SGD","LU1035775433.USD","LU2491049909.HKD","LU0096364046.USD","BK4533","LU2237443465.HKD","LU1804176565.USD","LU1069344957.HKD","LU1093756168.USD","BK4599","LU0256863902.USD","LU0882574055.USD","LU2491050154.USD","LU2112291526.USD","LU0456855351.SGD","LU1974910355.USD","BK4585","LLY","LU0198837287.USD","SG9999015952.SGD","LU0256863811.USD","LU2237443622.USD","LU0466842654.USD","LU0079474960.USD","LU0122379950.USD","SG9999018865.SGD","SGXZ31699556.SGD","LU1551013425.SGD","IE00B2B36J28.USD","SG9999014906.USD","SG9999017495.SGD","LU2750360997.AUD","LU0672654240.SGD","LU2106854487.HKD","IE00BK4W5L77.USD","LU0097036916.USD","LU2237443978.SGD","SGXZ81514606.USD","LU0320765992.SGD","BK4007","LU1917777945.USD","LU1551013342.USD","LU1061106388.HKD","LU2471134952.CNY","LU0353189763.USD","LU0689472784.USD","LU2746668974.SGD","LU2552382132.HKD"],"gpt_icon":0},{"id":"2568494407","title":"GLP-1 drugs could save millions of lives - and spark a pension crisis","url":"https://stock-news.laohu8.com/highlight/detail?id=2568494407","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568494407?lang=en_us&edition=fundamental","pubTime":"2025-09-17 22:05","pubTimestamp":1758117900,"startTime":"0","endTime":"0","summary":"GLP-1 drugs could save millions from premature death, according to projections from Swiss Re.Here's the good news: The GLP-1 class of weight-loss drugs is so powerful that, in 20 years, those drugs can save millions from premature death, a leading insurance company says.That's also the bad news: The increased longevity will extend the duration of pension payouts.That's the conclusion put forward in new research from Swiss Re , the reinsurance giant, about the weight-loss drugs from Novo Nordisk , Eli Lilly  and others.Swiss Re said that all-cause mortality could drop by up to 6.4% in the U.S. and by 5.1% in the U.K. due to the benefits of taking the drug.While the elderly population may enjoy the increased life expectancies, it could come with some additional costs - literally.\"While improved metabolic health may be positive for mortality and critical illness business, it could create financial pressure for longevity portfolios, as extended lifespans increase the duration of pension pa","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2471134796.USD","IE00BKVL7J92.USD","LU2417539215.USD","IE00B1BXHZ80.USD","LU1291159041.SGD","LU1917777945.USD","LU2236285917.USD","SG9999001176.USD","LU0203202063.USD","LU0106261372.USD","LU0471298694.HKD","LU2237443382.USD","LU2357305700.SGD","LU2468319806.SGD","LU0385154629.USD","LU0471298777.SGD","LU1127390331.HKD","LU2237443549.SGD","BK4599","LU0889565916.HKD","LU2746668974.SGD","LU0266013472.USD","BK4534","LU2237438978.USD","LU0353189763.USD","LU2471134523.USD","LLY","IE00BJJMRZ35.SGD","NVO","GB00BDT5M118.USD","LU0786609619.USD","LU1551013425.SGD","LU1720051017.SGD","IE00BZ1G4Q59.USD","BK4590","LU0122379950.USD","LU0323591593.USD","LU2264538146.SGD","LU1061106388.HKD","LU2461242641.AUD","LU2471134952.CNY","SG9999018857.SGD","SG9999014906.USD","LU2471134879.HKD","GLP","IE00B2B36J28.USD","IE00BJLML261.HKD","LU2237443978.SGD","LU1804176565.USD","LU1035775433.USD"],"gpt_icon":1},{"id":"2568449959","title":"Lilly's Oral Glp-1, Orforglipron, Superior to Oral Semaglutide in Head-to-Head Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2568449959","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568449959?lang=en_us&edition=fundamental","pubTime":"2025-09-17 21:00","pubTimestamp":1758114023,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nFWN3V40I7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","LU1868836591.USD","LU2468319806.SGD","LU0238689110.USD","LLY","LU2471134879.HKD","LU0456855351.SGD","LU1974910355.USD","LU2106854487.HKD","LU1720051017.SGD","LU1267930730.SGD","LU0109394709.USD","LU1868836757.USD","LU0354030438.USD","BK4599","SG9999001176.SGD","LU0256863902.USD","BK4588","LU0320765059.SGD","LU2462157665.USD","IE00B4R5TH58.HKD","LU2360106947.USD","LU2552382058.USD","LU2264538146.SGD","LU2112291526.USD","LU2089984988.USD","LU1814569148.SGD","LU1720051108.HKD","LU1623119135.USD","LU0198837287.USD","LU2211815571.USD","LU0114720955.EUR","LU0820561818.USD","LU2461242641.AUD","LU0323591593.USD","LU0234572021.USD","IE00BK4W5L77.USD","LU1548497426.USD","IE00BJJMRZ35.SGD","LU0094547139.USD","LU2265009873.SGD","LU1804176565.USD","LU2491050071.SGD","SG9999015945.SGD","IE00BJLML261.HKD","LU0640476718.USD","GB00BDT5M118.USD","LU2063271972.USD","LU1069344957.HKD","LU2471134796.USD"],"gpt_icon":0},{"id":"2568375499","title":"Eli Lilly: Orforglipron Met Primary, All Key Secondary Endpoints Across Each Dose Comparison VS Oral Semaglutide","url":"https://stock-news.laohu8.com/highlight/detail?id=2568375499","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568375499?lang=en_us&edition=fundamental","pubTime":"2025-09-17 21:00","pubTimestamp":1758114000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nP8N3M60E9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2237443549.SGD","LU0471298694.HKD","LU0353189763.USD","BK4516","LU1551013425.SGD","SGXZ31699556.SGD","LU0122379950.USD","LU0238689110.USD","BK4588","LU2211815571.USD","LU2552382215.SGD","SG9999001176.SGD","SGXZ81514606.USD","IE00BK4W5L77.USD","LU1712237335.SGD","LU1868836757.USD","LU0289739699.SGD","LU0094547139.USD","IE00BJJMRZ35.SGD","LU2324357040.USD","LU2237443978.SGD","LU0096364046.USD","LU1548497426.USD","LU0823416689.USD","LU2089984988.USD","LU0006306889.USD","LU0823434740.USD","LU2750360997.AUD","LLY","LU0385154629.USD","LU1093756325.SGD","LU0786609619.USD","LU0320765992.SGD","LU2361044865.SGD","BK4581","SG9999014880.SGD","SG9999018865.SGD","BK4599","LU2746668974.SGD","SG9999015952.SGD","LU1623119135.USD","LU0256863811.USD","LU0203202063.USD","LU0234572021.USD","SGXZ99366536.SGD","LU0256863902.USD","LU0882574139.USD","LU0114720955.EUR","BK4007","LU0354030511.USD"],"gpt_icon":0},{"id":"2568602264","title":"Citi Remains a Buy on Eli Lilly & Co (LLY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2568602264","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568602264?lang=en_us&edition=fundamental","pubTime":"2025-09-17 18:46","pubTimestamp":1758106006,"startTime":"0","endTime":"0","summary":"Citi analyst Geoff Meacham maintained a Buy rating on Eli Lilly & Co today. The company’s shares closed yesterday at $764.71. According to TipRanks...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-remains-a-buy-on-eli-lilly-co-lly-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-remains-a-buy-on-eli-lilly-co-lly-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0122379950.USD","LU0456855351.SGD","LU0471298694.HKD","BK4599","IE00BK4W5L77.USD","IE00BJLML261.HKD","LU2491049909.HKD","LU0256863902.USD","LU0354030511.USD","LU1291159041.SGD","LU2324357040.USD","SG9999015978.USD","SG9999018865.SGD","LU0882574055.USD","GB00BDT5M118.USD","SG9999014906.USD","IE00B4R5TH58.HKD","LU2357305700.SGD","SG9999001176.USD","LU2237443549.SGD","IE00BK4W5M84.HKD","LU2746668461.USD","LU1868836757.USD","IE00BFTCPJ56.SGD","LU0106261372.USD","LU0823416689.USD","LU2237443382.USD","LU1623119135.USD","LU1551013425.SGD","SG9999014914.USD","LU0672654240.SGD","LU1232071149.USD","LU2237443978.SGD","LU1988902786.USD","SGXZ51526630.SGD","LU1868837136.USD","LU2491050154.USD","LU2750360997.AUD","LU0079474960.USD","SGXZ31699556.SGD","LU0823434583.USD","SGXZ99366536.SGD","SG9999015986.USD","LLY","SG9999015945.SGD","LU0823434740.USD","LU1548497426.USD","LU0640476718.USD","LU2237443622.USD","LU0114720955.EUR"],"gpt_icon":0},{"id":"2568606544","title":"Eli Lilly Cut to Hold From Buy by Berenberg","url":"https://stock-news.laohu8.com/highlight/detail?id=2568606544","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568606544?lang=en_us&edition=fundamental","pubTime":"2025-09-17 18:46","pubTimestamp":1758105960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LLY/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 17, 2025 06:46 ET (10:46 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","LU0122379950.USD","LU2750360997.AUD","SG9999018865.SGD","LU2602419157.SGD","LU1988902786.USD","LLY","LU1868837300.USD","LU1974910355.USD","LU2106854487.HKD","LU2324357040.USD","LU0109394709.USD","BK4516","LU0471298694.HKD","LU0823434740.USD","LU1868836757.USD","BK4599","LU2108987350.USD","LU0320765059.SGD","SGXZ31699556.SGD","SGXZ99366536.SGD","LU2360106947.USD","LU2089984988.USD","LU0266013472.USD","BK4007","LU2237443465.HKD","SG9999017495.SGD","LU0096364046.USD","LU2471134523.USD","LU0079474960.USD","LU0198837287.USD","LU1093756168.USD","LU2491050154.USD","LU1023059063.AUD","SG9999014906.USD","IE00BJT1NW94.SGD","LU0234572021.USD","LU0109391861.USD","LU0353189763.USD","LU2087625088.SGD","LU2491050071.SGD","SG9999015945.SGD","LU2023250504.SGD","LU1127390331.HKD","IE00BJLML261.HKD","LU2471134952.CNY","LU0640476718.USD","LU1069344957.HKD","LU0786609619.USD","LU2237443895.HKD"],"gpt_icon":0},{"id":"1198812339","title":"Eli Lilly Bets on Consumer-Oriented Strategy, Expects Weight Loss Drug Breakthrough in US Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1198812339","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198812339?lang=en_us&edition=fundamental","pubTime":"2025-09-17 18:21","pubTimestamp":1758104511,"startTime":"0","endTime":"0","summary":"Eli Lilly's president of international business told Reuters on Wednesday that the company has established a leading position in obesity drug markets across Europe, Asia, and the Middle East, and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014898.SGD","LU1023059063.AUD","LU2360106947.USD","LU2211815571.USD","LU0238689110.USD","LU0203201768.USD","SG9999014880.SGD","LU0234572021.USD","LU0114720955.EUR","LU0823434583.USD","BK4534","LU2237443978.SGD","LU0889565916.HKD","SG9999018865.SGD","IE00BJT1NW94.SGD","LU0417517546.SGD","IE00B1BXHZ80.USD","LU2471134523.USD","LU0820561818.USD","LU1814569148.SGD","LU2237443465.HKD","LU0640476718.USD","LU0385154629.USD","BK4581","BK4585","IE00BFTCPJ56.SGD","LU2461242641.AUD","BK4007","IE00BJJMRZ35.SGD","LU2087625088.SGD","LU1868837300.USD","LU0061475181.USD","LU0689472784.USD","LU1267930730.SGD","LU0353189763.USD","LLY","SG9999013999.USD","SG9999015952.SGD","LU0882574139.USD","LU2491050154.USD","LU0289739699.SGD","IE0009355771.USD","LU0094547139.USD","LU1548497426.USD","LU2264538146.SGD","LU2357305700.SGD","LU0432979614.USD","LU1232071149.USD","SG9999015978.USD","LU1366192091.USD","LU2471134796.USD","LU2089984988.USD","SGXZ57979304.SGD","LU2063271972.USD","LU2265009873.SGD","LU2324357040.USD","LU0820561909.HKD","LU0096364046.USD","LU2237443382.USD","LU2468319806.SGD","LU2491049909.HKD","IE00BK4W5L77.USD","SG9999017495.SGD","LU1720051017.SGD","LU0471298777.SGD","LU1868836591.USD","LU1057294990.SGD","IE00BJLML261.HKD","SGXZ31699556.SGD","LU2552382215.SGD","LU1917777945.USD","LU0354030438.USD","LU1868836914.USD","SG9999014906.USD","LU0320765059.SGD","LU1069344957.HKD","LU1035775433.USD","LU0198837287.USD","LU1868837136.USD","LU2108987350.USD","SGXZ51526630.SGD","BK4588","LU0079474960.USD","LU2602419157.SGD","IE0002141913.USD","BK4533","LU2023250504.SGD","LU2361044865.SGD","LU0823434740.USD","LU0466842654.USD","LU0256863902.USD","LU1983299246.USD","LU0266013472.USD","LU1093756168.USD","LU0943347566.SGD","LU0882574055.USD","LU2746668974.SGD","BK4599","LU0256863811.USD","LU0323591593.USD","BK4516","LU2112291526.USD","LU0672654240.SGD","LU2471134952.CNY","LU0006306889.USD","LU1280957306.USD","SG9999018857.SGD","SG9999015945.SGD","IE00B4R5TH58.HKD","LU1974910355.USD","LU2106854487.HKD","LU1551013425.SGD","LU2417539215.USD","LU2361044949.HKD","LU0353189680.USD","LU1712237335.SGD","LU1804176565.USD","LU2552382058.USD","LU2462157665.USD","LU0097036916.USD","LU1061106388.HKD","LU2750360641.GBP","SG9999015986.USD","SGXZ99366536.SGD","LU0786609619.USD","LU0109391861.USD","LU0708995401.HKD","LU1291159041.SGD","LU0058720904.USD","LU1989771016.USD","LU1127390331.HKD","LU2237443549.SGD","GB00BDT5M118.USD","LU0823416689.USD","IE00BK4W5M84.HKD","LU2750360997.AUD","SG9999001176.USD","SG9999014914.USD","LU0203202063.USD","LU0471298694.HKD","LU2237443895.HKD","LU0122379950.USD","IE0004445239.USD","LU0109394709.USD","SGXZ81514606.USD","LU2237438978.USD","LU1868836757.USD","LU2491050071.SGD","LU0316494557.USD","LU0354030511.USD","LU2361045086.USD","IE00B2B36J28.USD","LU2237443622.USD","LU0456855351.SGD","LU2746668461.USD","LU1064131342.USD","LU0106261372.USD","LU2552382132.HKD","SG9999001176.SGD","LU1623119135.USD","LU2471134879.HKD","LU1720051108.HKD","LU2236285917.USD","LU2456880835.USD","LU0320765992.SGD","LU1988902786.USD","LU1551013342.USD","LU1093756325.SGD"],"gpt_icon":1},{"id":"2568461747","title":"2 High-Yield Dividend Stocks You'll Wish You Had Bought 10 Years From Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2568461747","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568461747?lang=en_us&edition=fundamental","pubTime":"2025-09-17 17:16","pubTimestamp":1758100560,"startTime":"0","endTime":"0","summary":"These dividend payers cranked up their payouts over the past decade, and they could do it again.","market":"nz","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F833596%2Findividual-investor-with-devices-getty.jpg&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F833596%2Findividual-investor-with-devices-getty.jpg&op=resize&w=165&h=104"],"rights":{"source":"fool_stock","url":"https://www.fool.com/investing/2025/09/17/2-high-yield-dividend-stocks-youll-wish-you-had-bo/","rn_cache_url":null,"customStyle":"","selectors":".main-contain, #article-page","filters":"#sticky-wrapper, .navigation, .article-page-end, .foot, .author-tagline, .author-inline, .footer, .soc-share, .wysiwyg, .related-content","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/09/17/2-high-yield-dividend-stocks-youll-wish-you-had-bo/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["IE00BZ199S13.USD","US3Y.BOND","LU1046421795.USD","US6M.BOND","LU0154236417.USD","LU1674673691.USD","BK4599","LU2413666699.HKD","LU0553294199.USD","TXN","US2Y.BOND","BK4561","LU0345774631.USD","US30Y.BOND","BK4534","BK4554","BK4532","LU0738911758.USD","LU1066051498.USD","LU2129689514.USD","LU1244550577.SGD","SG9999011175.SGD","BK4533","US10Y.BOND","LU1983260115.SGD","BK4141","IE0008368304.USD","US5Y.BOND","BK4585","IE00BYQQ9H92.USD","BK4512","LU0661504455.SGD","LU2129689605.HKD","LU2413666426.HKD","IE00BFXG0V08.USD","US12M.BOND","BK4567","LU2129689431.USD","BK4581","IE0009356076.USD","LU0234570918.USD","LU0345774391.USD","LU1093756325.SGD","BK4007","NVO","LU1778281490.HKD","LU1003077747.HKD","LU1244550221.USD","LU1235294995.USD","US7Y.BOND"],"gpt_icon":1},{"id":"1125151854","title":"Novo-Nordisk A/S (NVO.US) Weight-Loss Drug Patents Set to Expire in Multiple Markets Next Year as Indian API Manufacturers Target $94 Billion Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1125151854","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125151854?lang=en_us&edition=fundamental","pubTime":"2025-09-17 16:08","pubTimestamp":1758096514,"startTime":"0","endTime":"0","summary":"Indian companies specializing in Active Pharmaceutical Ingredients (APIs) are actively preparing to supply key raw materials for generic versions of Novo-Nordisk A/S (NVO.US) weight-loss medications,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4007","BK4588","LU1093756325.SGD","IE00BKVL7J92.USD","LU1093756168.USD","MNDmain","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4599","BK4585","NVO"],"gpt_icon":1},{"id":"2568468086","title":"Eli Lilly's International President Says Co Looking Into New FDA Fast-Track Review Process but Cannot Assume New Obesity Pill Could Be Approved This Way","url":"https://stock-news.laohu8.com/highlight/detail?id=2568468086","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568468086?lang=en_us&edition=fundamental","pubTime":"2025-09-17 15:24","pubTimestamp":1758093883,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nL3N3V40G4:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4516","LU2106854487.HKD","LU0234572021.USD","LU2552382215.SGD","IE00B1BXHZ80.USD","LU1623119135.USD","LU2361045086.USD","LU0471298777.SGD","SG9999014898.SGD","LU0316494557.USD","LU0708995401.HKD","LU1720051017.SGD","SG9999015945.SGD","LU1280957306.USD","LU1035775433.USD","LU1804176565.USD","SG9999015952.SGD","LU0114720955.EUR","LU1232071149.USD","BK4585","LU1868837300.USD","LU2236285917.USD","LU1267930730.SGD","LU0354030438.USD","LU2360106947.USD","LU2552382058.USD","LU0323591593.USD","LLY","LU0823434583.USD","BK4534","LU0079474960.USD","LU0289739699.SGD","LU0109394709.USD","LU2087625088.SGD","LU0417517546.SGD","IE0009355771.USD","IE00BJLML261.HKD","SGXZ99366536.SGD","LU1057294990.SGD","BK4599","IE00BJJMRZ35.SGD","LU1989771016.USD","LU2471134952.CNY","LU1720051108.HKD","LU2361044949.HKD","IE0004445239.USD","SGXZ57979304.SGD","LU0689472784.USD","LU2324357040.USD","SGXZ51526630.SGD"],"gpt_icon":0},{"id":"2568468703","title":"Eli Lilly’s International President Says Co Has Partnered With Telehealth Platforms Run by Alibaba & Jd to Boost Obesity Drug Awareness, Sales in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2568468703","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568468703?lang=en_us&edition=fundamental","pubTime":"2025-09-17 15:23","pubTimestamp":1758093826,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nL3N3V40G4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0823416689.USD","LU2112291526.USD","LLY","LU2360106947.USD","LU1023059063.AUD","LU0203201768.USD","LU2087625088.SGD","LU1064131342.USD","LU0238689110.USD","LU0672654240.SGD","LU2417539215.USD","LU2471134523.USD","LU2456880835.USD","LU1868836757.USD","LU2746668974.SGD","LU2236285917.USD","IE00BFTCPJ56.SGD","SGXZ51526630.SGD","LU0820561909.HKD","LU0823434740.USD","IE00B4R5TH58.HKD","LU0203202063.USD","BK4599","LU1868836591.USD","LU1291159041.SGD","SGXZ57979304.SGD","LU0640476718.USD","LU1868836914.USD","LU2491050154.USD","LU1974910355.USD","LU0466842654.USD","SG9999013999.USD","LU2471134952.CNY","SG9999014914.USD","SG9999015952.SGD","LU2552382058.USD","LU0889565916.HKD","LU2237443978.SGD","LU0234572021.USD","LU0109394709.USD","LU0882574139.USD","LU0106261372.USD","LU0353189763.USD","LU0820561818.USD","BK4581","IE0004445239.USD","LU0058720904.USD","LU2361044949.HKD","LU0006306889.USD","LU0316494557.USD"],"gpt_icon":0},{"id":"2568846870","title":"Eli Lilly's International President Says Co Replicating U.S. Consumer-Focused Obesity Strategy in UK, China, UAE, Australia, Elsewhere","url":"https://stock-news.laohu8.com/highlight/detail?id=2568846870","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568846870?lang=en_us&edition=fundamental","pubTime":"2025-09-17 15:23","pubTimestamp":1758093801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nL3N3V40G4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SGXZ31699556.SGD","LU0061475181.USD","IE00B4R5TH58.HKD","GB00BDT5M118.USD","BK4533","LU0266013472.USD","LU2746668974.SGD","LU1291159041.SGD","LU1061106388.HKD","LU1989771016.USD","LU0820561909.HKD","SG9999015978.USD","LU0238689110.USD","IE00B1BXHZ80.USD","LU0882574055.USD","SG9999014906.USD","LU2237443895.HKD","LU0058720904.USD","LU1868837136.USD","LU1804176565.USD","LU2471134879.HKD","LU1267930730.SGD","LU1623119135.USD","LU2552382215.SGD","BK4534","LU0097036916.USD","LU0823416689.USD","SG9999001176.SGD","LU1551013425.SGD","LU2063271972.USD","LU1720051017.SGD","LU0289739699.SGD","BK4599","LU0096364046.USD","BK4516","LU0823434740.USD","LU0786609619.USD","LU1232071149.USD","LU0323591593.USD","SG9999017495.SGD","LLY","LU0198837287.USD","LU0354030438.USD","LU1366192091.USD","LU2264538146.SGD","LU0234572021.USD","LU1069344957.HKD","IE00BK4W5M84.HKD","LU2602419157.SGD","LU2417539215.USD"],"gpt_icon":0},{"id":"2568455452","title":"Novo Nordisk Has Opportunities to Seize After Market Reset -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2568455452","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568455452?lang=en_us&edition=fundamental","pubTime":"2025-09-17 13:52","pubTimestamp":1758088320,"startTime":"0","endTime":"0","summary":"0551 GMT - Novo Nordisk still has hurdles to clear, but there are also opportunities to seize, Berenberg analysts write. Since a share-price peak in mid-2024, there has been multiple guidance downgrades and a significant reset in market expectations. This allows for a more constructive debate on growth, catalysts and valuation, Berenberg adds. Catalysts include Wegovy's possible FDA approval for fatty liver disease and heart failure by year-end and the launch of a Wegovy pill in early 2026. News of cost-cutting is well-received while physicians appear enthusiastic over CagriSema, Berenberg adds. The bank switches its preference in obesity to Novo Nordisk from Eli Lilly. It upgrades its stock rating to buy from hold and lowers its price target to 425 Danish kroner from 610 kroner. Shares closed at 359.10 kroner. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","BK4599","BK4007","NVO","IE00BKVL7J92.USD","LU0154236417.USD","LU1093756325.SGD","IE00BZ1G4Q59.USD","BK4532","BK4588","BK4585"],"gpt_icon":1},{"id":"2568454925","title":"Eli Lilly : Berenberg Cuts to Hold From Buy; Cuts Target Price to $830 From $970","url":"https://stock-news.laohu8.com/highlight/detail?id=2568454925","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568454925?lang=en_us&edition=fundamental","pubTime":"2025-09-17 13:06","pubTimestamp":1758085590,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nFWN3V402K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1551013425.SGD","LU1868836591.USD","LU1983299246.USD","LU2361044949.HKD","LU1069344957.HKD","LU1093756168.USD","LU0096364046.USD","LU1280957306.USD","LU1814569148.SGD","LU0323591593.USD","IE00B1BXHZ80.USD","SG9999015986.USD","LU2237443622.USD","LU0109391861.USD","LU0109394709.USD","LU0122379950.USD","LU0289739699.SGD","LU0823434583.USD","LU0353189763.USD","BK4581","LU0708995401.HKD","SG9999014914.USD","LU0882574055.USD","LU0234572021.USD","LU0823434740.USD","LU2265009873.SGD","SG9999017495.SGD","BK4599","LU2456880835.USD","IE00BK4W5L77.USD","LU1804176565.USD","LU2063271972.USD","LU0079474960.USD","IE00B2B36J28.USD","LU1868836757.USD","IE0004445239.USD","LU1988902786.USD","LU2087625088.SGD","LU1093756325.SGD","LU2552382132.HKD","BK4588","LU2552382215.SGD","LU0006306889.USD","LU0456855351.SGD","LU2237443549.SGD","LU0316494557.USD","IE00BK4W5M84.HKD","LLY","GB00BDT5M118.USD","BK4516"],"gpt_icon":0},{"id":"2568743481","title":"GSK Says It Will Spend $30B on U.S. Manufacturing and R&D -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2568743481","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568743481?lang=en_us&edition=fundamental","pubTime":"2025-09-17 07:01","pubTimestamp":1758063660,"startTime":"0","endTime":"0","summary":"The U.K.-based drugmaker GSK said late Tuesday that it plans to invest $30 billion over the next five years in the U.S., making it the latest drugmaker promising big spending on U.S. infrastructure.President Donald Trump has made expanding domestic manufacturing a priority in his second term, while threatening tariffs as high as 200% on pharmaceutical imports. Drugmakers, in response, have been scrambling to plan multibillion-dollar investments in their U.S. operations.GSK offered few details on the $30 billion headline number in its Tuesday press release. Its statement detailed plans for a $1.2 billion investment that would include construction of a manufacturing factory in Pennsylvania, set to begin next year, along with new AI capabilities to existing GSK manufacturing sites in the U.S.Drugmakers like GSK have found themselves at the center of multiple Trump administration proposals, as the president and his allies have pushed for lower drug prices, higher drug tariffs, and limits o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0792757196.USD","IE00B19Z3B42.SGD","LU2324357040.USD","LU2505996681.GBP","LU1894683264.USD","JNJ","LU2129689514.USD","LU2360106947.USD","IE00BLSP4452.SGD","LU0203202063.USD","SG9999013999.USD","LU1868836591.USD","03165","LU2430703251.USD","LU0203201768.USD","LU1868837136.USD","AZN","LU1059921491.USD","GSK","LU0985320562.USD","LU0640476718.USD","LU1069344957.HKD","LU0256863811.USD","LU1093756325.SGD","LU1674673691.USD","LU2456880835.USD","IE00BJLML261.HKD","IE00BJJMRZ35.SGD","LU1674673428.USD","LU2237443978.SGD","LU2129689605.HKD","BK4599","LU1061106388.HKD","LU1868836757.USD","IE00B3T34201.USD","LU1066053197.SGD","LU0354030438.USD","IE00BLSP4239.USD","LU1989771016.USD","LU1983299246.USD","LU0354030511.USD","LU2505996509.AUD","RHHBY","IE0002141913.USD","GSK.UK","LU1914381329.SGD","LU2430703178.SGD","LU0096364046.USD","LU1868837300.USD"],"gpt_icon":1},{"id":"2568355004","title":"Moderna Inc. Stock Rises 4.0%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2568355004","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568355004?lang=en_us&edition=fundamental","pubTime":"2025-09-17 04:34","pubTimestamp":1758054840,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rose 4.0% to $24.84 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.1% to 22,333.96 and Dow Jones Industrial Average falling 0.3% to 45,757.90.This was the stock's second consecutive day of gains.Moderna Inc. closed 67.0% below its 52-week high of $75.37, which the company achieved on September 17th.The stock outperformed some of its peers, as Johnson & Johnson fell 0.5% to $176.46, Pfizer Inc. fell 0.3% to $23.90, and Gilead Sciences Inc. fell 1.49% to $110.86.Trading volume totaled 15.6 million, compared to the 50-day average of 9.9 million.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4592","LU0234572021.USD","LU0321505439.SGD","BK4501","LU0306807586.USD","SGXZ57979304.SGD","BK4007","SG9999003800.SGD","MRNA","LU0225284248.USD","SG9999013999.USD","IE00B19Z3581.USD","BK4548","LU0306806265.USD","BK4568","IE0002270589.USD","LU1066051498.USD","IE000M9KFDE8.USD","SG9999002232.USD","LU0225771236.USD","IE00B19Z3B42.SGD","BK4585","LU0985481810.HKD","BK4139","LU1066053197.SGD","SG9999002224.SGD","LU0058720904.USD","BK4533","IE00BLSP4452.SGD","BK4532","LU0122379950.USD","SG9999011175.SGD","LU0321505868.SGD","SG9999001176.SGD","BK4550","LU1057294990.SGD","LU1023059063.AUD","BK4599","BK4581","BK4551","BK4588","LU0456855351.SGD","LU1894683348.USD","LU0170899867.USD","LU1883839398.USD","IE00BBT3K403.USD","BK4534","LU1894683264.USD","IE00BLSP4239.USD"],"gpt_icon":1},{"id":"2568484480","title":"Stock Of The Day: Is The Novo Nordisk Death Spiral Finally Over?","url":"https://stock-news.laohu8.com/highlight/detail?id=2568484480","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568484480?lang=en_us&edition=fundamental","pubTime":"2025-09-17 00:25","pubTimestamp":1758039900,"startTime":"0","endTime":"0","summary":"Novo Nordisk has been in a downtrend for more than a year. But a reversal may be underway, and a rally may follow.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/09/16/Novo-Nordisk-Advertising-Logo-On-Facade-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/09/16/Novo-Nordisk-Advertising-Logo-On-Facade-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/25/09/47697305/stock-of-the-day-is-the-novo-nordisk-death-spiral-finally-over","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/09/47697305/stock-of-the-day-is-the-novo-nordisk-death-spiral-finally-over","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU1093756168.USD","BK4007","NVO","LU1093756325.SGD","BK4585","BK4599","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4532","BK4588","LU0154236417.USD"],"gpt_icon":1},{"id":"2568846784","title":"FDA sends Novo Nordisk warning letter over weight loss video","url":"https://stock-news.laohu8.com/highlight/detail?id=2568846784","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568846784?lang=en_us&edition=fundamental","pubTime":"2025-09-17 00:00","pubTimestamp":1758038445,"startTime":"0","endTime":"0","summary":"The FDA posted a warning letter sent to Novo Nordisk (NVO) over a weight loss video the agency deems “false or misleading.” The letter states, “The...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-sends-novo-nordisk-warning-letter-over-weight-loss-video-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-sends-novo-nordisk-warning-letter-over-weight-loss-video-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0154236417.USD","BK4007","IE00BKVL7J92.USD","LU1093756168.USD","BK4599","NVO","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4588","BK4532","BK4585"],"gpt_icon":0},{"id":"1150314097","title":"Eli Lilly Plans $5 Billion Investment for New Manufacturing Facility in Virginia","url":"https://stock-news.laohu8.com/highlight/detail?id=1150314097","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150314097?lang=en_us&edition=fundamental","pubTime":"2025-09-16 23:41","pubTimestamp":1758037267,"startTime":"0","endTime":"0","summary":"Eli Lilly announced on Tuesday that it will invest $5 billion to build a production facility in Virginia. This represents the first of four planned manufacturing plants the pharmaceutical company...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","IE00BJLML261.HKD","LU2237443978.SGD","LU1974910355.USD","LU2237443895.HKD","LU2237443382.USD","SG9999018865.SGD","LU1868837136.USD","LU2462157665.USD","LU1868837300.USD","LU0889565916.HKD","LU0114720955.EUR","LU2491050154.USD","LU0203201768.USD","LU2106854487.HKD","GB00BDT5M118.USD","LU1983299246.USD","LU0943347566.SGD","SGXZ57979304.SGD","IE00B1BXHZ80.USD","LU2746668461.USD","LU0234572021.USD","LU0096364046.USD","LU0316494557.USD","LU0323591593.USD","SGXZ51526630.SGD","LU2461242641.AUD","LU2324357040.USD","LU2211815571.USD","LU2361044865.SGD","LU2746668974.SGD","LU0256863902.USD","LU1988902786.USD","IE00B2B36J28.USD","SG9999015978.USD","BK4581","LU2471134523.USD","LU1267930730.SGD","LU2023250504.SGD","SG9999013999.USD","IE0004445239.USD","LU1069344957.HKD","LU2552382132.HKD","LU0289739699.SGD","LU2468319806.SGD","BK4588","LU2237443549.SGD","SG9999017495.SGD","LU0354030511.USD","LU2602419157.SGD","LU1868836591.USD","LU0122379950.USD","LU0882574139.USD","LU2417539215.USD","LU0820561909.HKD","LU1127390331.HKD","LU2552382058.USD","LU0058720904.USD","SGXZ99366536.SGD","LU0256863811.USD","LU1061106388.HKD","LU1551013425.SGD","LU2361044949.HKD","LU0417517546.SGD","LU1023059063.AUD","LU1232071149.USD","LU0708995401.HKD","LU1712237335.SGD","LU0198837287.USD","LU1064131342.USD","LU1814569148.SGD","LU0882574055.USD","LU2471134879.HKD","LU0320765992.SGD","LU1989771016.USD","SG9999014906.USD","BK4533","LU1093756168.USD","LU1035775433.USD","LU0786609619.USD","BK4007","LU2108987350.USD","SG9999014898.SGD","LU0456855351.SGD","LU1366192091.USD","SGXZ31699556.SGD","LU0823434740.USD","BK4585","LU2360106947.USD","LU0266013472.USD","LU1548497426.USD","LU2750360997.AUD","LU1551013342.USD","LU2087625088.SGD","LU1804176565.USD","LU2237443622.USD","LU0823434583.USD","LU1291159041.SGD","IE00BJJMRZ35.SGD","LU0640476718.USD","LU0109394709.USD","LU2237438978.USD","SG9999015986.USD","LU0006306889.USD","LU0097036916.USD","LU0079474960.USD","LU0385154629.USD","LU0820561818.USD","LU2471134796.USD","LU0689472784.USD","LU2112291526.USD","IE0002141913.USD","LU0109391861.USD","SG9999014914.USD","BK4534","LU0061475181.USD","LU2750360641.GBP","LU2264538146.SGD","IE00B4R5TH58.HKD","LU2265009873.SGD","LU1917777945.USD","LU2361045086.USD","SG9999015952.SGD","LU0238689110.USD","LU0471298777.SGD","SGXZ81514606.USD","LU0432979614.USD","BK4599","LU0353189763.USD","LU0466842654.USD","LU0094547139.USD","LU1868836914.USD","LU0106261372.USD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU2491049909.HKD","LU2491050071.SGD","LU0471298694.HKD","LU0203202063.USD","SG9999001176.SGD","SG9999018857.SGD","LU0672654240.SGD","LU2236285917.USD","LU0354030438.USD","SG9999015945.SGD","LU0353189680.USD","LU2237443465.HKD","LU0823416689.USD","LU2089984988.USD","LU1720051108.HKD","LU1623119135.USD","LU2456880835.USD","SG9999001176.USD","LU0320765059.SGD","LU1280957306.USD","LLY","BK4516","LU2471134952.CNY","LU1868836757.USD","LU2552382215.SGD","LU1093756325.SGD","IE0009355771.USD","SG9999014880.SGD","LU2357305700.SGD","IE00BK4W5L77.USD","LU1720051017.SGD","LU2063271972.USD","IE00BK4W5M84.HKD"],"gpt_icon":1}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":148,"code":"91000000","status":"200"}]}}